Neuroinflammation in Plaque and Vascular β-Amyloid Disorders: Clinical and Therapeutic Implications
Authors:
- Piet EikelenboomPEPiet Eikelenboom
- Rob VeerhuisRVRob Veerhuis
- Atoosa FamilianAFAtoosa Familian
- Jeroen J.M. HoozemansJHJeroen J.M. Hoozemans
- Willem A. van GoolWGWillem A. van Gool
- Annemieke J.M. RozemullerARAnnemieke J.M. Rozemuller
- 1 March 2008
- journal article
- review article
- Published by S. Karger AG in Neurodegenerative Diseases
- Vol. 5 (3-4) , 190-193
Abstract
Background: The cerebral β-amyloid (Aβ) disorders show a great variability in the distribution of parenchymal and vascular amyloid deposits. Objective: To study the relationship between amyloid deposition and inflammatory responses in three distinct subtypes of cerebral Aβ disorders. Methods: The distribution of inflammatory proteins and cells in vascular and plaque amyloid deposits was evaluated in postmortem brain tissue using immunohistochemistry. The effects of a mixture of Aβ peptides and inflammation-related Aβ-associated proteins were studied in postmortem obtained human microglia cell cultures. Results: The chronic inflammatory response is associated with amyloid plaques (but not with amyloid in the walls of larger vessels) in Alzheimer’s disease (AD), with amyloid in cerebral arteries in hereditary cerebral hemorrhage with amyloidosis-Dutch type and with amyloid microangiopathy in the vascular variant of AD. Aβ1–42 fibrils complexed with complement factor C1q and serum amyloid P component (the relevant amyloid-associated proteins) stimulate the production of proinflammatory cytokines in human microglia cell cultures and this production is attenuated by minocycline. Conclusion: The pattern of the chronic inflammatory response associated with fibrillar Aβ is strikingly different in the three studied types of Aβ disorders. The site of the fibrillar Aβ-induced chronic inflammatory response is closely related to clinical symptoms. Minocycline is a drug of interest to inhibit microglia-mediated neuroinflammatory response in Aβ brain disorders.Keywords
This publication has 10 references indexed in Scilit:
- Minocycline does not affect amyloid β phagocytosis by human microglial cellsNeuroscience Letters, 2007
- Minocycline Reduces Microglial Activation and Improves Behavioral Deficits in a Transgenic Model of Cerebral Microvascular AmyloidJournal of Neuroscience, 2007
- Inhibitory effect of minocycline on amyloid β fibril formation and human microglial activationGlia, 2005
- Cerebral Microvascular Amyloid β Protein Deposition Induces Vascular Degeneration and Neuroinflammation in Transgenic Mice Expressing Human Vasculotropic Mutant Amyloid β Precursor ProteinThe American Journal of Pathology, 2005
- The Neuroinflammatory Response in Plaques and Amyloid Angiopathy in Alzheimers Disease: Therapeutic ImplicationsCurrent Drug Targets-CNS & Neurological Disorders, 2005
- Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosisNature Neuroscience, 2004
- Microglial activation facilitates Aβ plaque removal following intracranial anti-Aβ antibody administrationNeurobiology of Disease, 2004
- Amyloid β plaque-associated proteins C1q and SAP enhance the Aβ1–42 peptide-induced cytokine secretion by adult human microglia in vitroActa Neuropathologica, 2003
- Vascular Variant of Alzheimer's Disease Characterized by Severe Plaque-Like β Protein AngiopathyDementia and Geriatric Cognitive Disorders, 1997
- Association of Vascular Amyloid β and Cells of the Mononuclear Phagocyte System in Hereditary Cerebral Hemorrhage with Amyloidosis (Dutch) and Alzheimer DiseaseJournal of Neuropathology & Experimental Neurology, 1997